Mark Leick
Harvard University
H-index: 17
North America-United States
Top articles of Mark Leick
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Tandem CAR-T cells against mesothelin and MUC16ectoto overcome tumor-antigen heterogenicity | Cancer Research | Diego Salas-Benito Filippo Birocchi Alexander Armstrong Amanda A Bouffard Tamina Kienka | 2024/3/22 |
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7 | Leukemia | Michael C Kann Emily M Schneider Antonio J Almazan Isabel C Lane Amanda A Bouffard | 2024/3 |
Optimization of a flow cytometry test for routine monitoring of B cell maturation antigen targeted CAR in peripheral blood | Cytometry Part B: Clinical Cytometry | Won‐Ho Lee Charlotte E Graham Hadley R Wiggin Hannah K Nolan Kiana J Graham | 2024/2/28 |
Genetic retargeting of E3 ligases to enhance CAR T cell therapy | Cell Chemical Biology | Isabel C Lane Gabriele Kembuan Jeannie Carreiro Michael C Kann William Lin | 2024/2/15 |
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma | Clinical Cancer Research | Marc Wehrli Samantha Guinn Filippo Birocchi Adam Kuo Yi Sun | 2024/4/2 |
Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide | Bone Marrow Transplantation | Daniel J Ikeda Zachariah DeFilipp Kerry Collier Yi-Bin Chen Bimalangshu R Dey | 2024/1 |
Intraventricular CARv3-TEAM-E T cells in recurrent glioblastoma | New England Journal of Medicine | Bryan D Choi Elizabeth R Gerstner Matthew J Frigault Mark B Leick Christopher W Mount | 2024/4/11 |
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma | Neuro-Oncology Advances | Andrea Schmidts Ambike A Srivastava Rishab Ramapriyan Stefanie R Bailey Amanda A Bouffard | 2023/1/1 |
310 Targeted delivery of a VEGF-blocking scFv to enhance CAR-T cell potency | Valentina Supper Hannah Donner Michael Kann Filippo Birocchi Felix Korell | 2023/11/1 | |
Chemotherapy-induced reversal of ciltacabtagene autoleucel–associated movement and neurocognitive toxicity | Blood | Charlotte E Graham Won-Ho Lee Hadley R Wiggin Valentina M Supper Mark B Leick | 2023/10/5 |
Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome | Transplantation and Cellular Therapy | Melissa R Hines Tristan E Knight Kevin O McNerney Mark B Leick Tania Jain | 2023/7/1 |
Multiomics STEP up in correlative analysis of response to CAR T cells | Mark B Leick Marcela V Maus | 2023/5 | |
Chimeric antigen receptor (CAR) T cells overexpressing Bcl-xL increase proliferation and antitumor activity alone and in combination with BH3 mimetics | Cancer Research | Felix Korell Michael Olson Diego Salas-Benito Mark B Leick Rebecca C Larson | 2023/4/4 |
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies | Ana Antunes Luis Álvarez-Vallina Federico Bertoglio Nicolas Bouquin Stéphanie Cornen | 2023/12/31 | |
Loss of IFNgR1 signaling glioblastoma drives resistance to CAR T cell binding avidity and cytotoxicity due to lower downstream expression of ICAM-1 | The Journal of Immunology | Rebecca Larson Michael Kann Stefanie Bailey Nicholas Haradhvala Kai Stewart | 2022/5/1 |
Blockade or deletion of IFNγ reduces macrophage activation without compromising CAR T-cell function in hematologic malignancies | Blood Cancer Discovery | Stefanie R Bailey Sonika Vatsa Rebecca C Larson Amanda A Bouffard Irene Scarfò | 2022/3/1 |
Differential T-cell immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mRNA-1273–and BNT162b2-vaccinated individuals | Clinical Infectious Diseases | Kathleen ME Gallagher Mark B Leick Rebecca C Larson Trisha R Berger Katelin Katsis | 2022/7/1 |
Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals | The Journal of Immunology | Katelin Katsis Mark B Leick Rebecca C Larson Trisha R Berger Eva L Elder | 2022/5/1 |
Differential dynamics of response at single cell resolution between axi-cel and tisa-cel CAR-T therapy in refractory B-cell lymphomas | Cancer Research | Nicholas J Haradhvala Mark B Leick Katie Maurer Satyen Gohil Rebecca C Larson | 2022/6/15 |
A glimpse into what happens after PTCy | Blood, The Journal of the American Society of Hematology | Mark Leick Yi-Bin Chen | 2022/1/27 |
Co-Authors
